QLT, Inc. (QLTI) Shareholders Approve Aegerion Pharmaceuticals Merger
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/24/2024
- S&P 500 ends higher as markets weigh rising yields, upbeat corporate results
- Meta Platforms reports softer Q2 revenue guidance on plans to boost spending on AI
- IBM (IBM) announces mixed Q1 results, HashiCorp acquisition; shares down
- Equities mixed as investors eye earnings; yen on intervention watch
- ServiceNow (NOW) stock falls as refreshed subscription outlook trails estimates
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Hasbro (HAS) brand strength sees earnings top expectations
- IBM (IBM) announces mixed Q1 results, HashiCorp acquisition; shares down
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
QLT Announces Shareholder Approval of Matters Related to Strategic Merger and Record Date for Distribution of Warrants
November 7, 2016 5:30 PM ESTVANCOUVER, British Columbia, Nov. 07, 2016 (GLOBE NEWSWIRE) -- QLT Inc. (NASDAQ: QLTI) (TSX: QLT) (QLT) announced today certain matters relating to the previously announced transactions (the Transactions) contemplated in connection with an agreement and plan of merger dated as of June 14, 2016 (the Merger Agreement) involving QLT and Aegerion Pharmaceuticals, Inc. (Aegerion).
Shareholder Approval
QLT is pleased to... More
